These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31692391)

  • 1. Is Engrailed-2 (EN2) a truly promising biomarker in prostate cancer detection?
    Do Carmo Silva J; Vesely S; Novak V; Luksanova H; Prusa R; Babjuk M
    Biomarkers; 2020 Feb; 25(1):34-39. PubMed ID: 31692391
    [No Abstract]   [Full Text] [Related]  

  • 2. Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer.
    Morgan R; Boxall A; Bhatt A; Bailey M; Hindley R; Langley S; Whitaker HC; Neal DE; Ismail M; Whitaker H; Annels N; Michael A; Pandha H
    Clin Cancer Res; 2011 Mar; 17(5):1090-8. PubMed ID: 21364037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
    Pandha H; Sorensen KD; Orntoft TF; Langley S; Hoyer S; Borre M; Morgan R
    BJU Int; 2012 Sep; 110(6 Pt B):E287-92. PubMed ID: 22583908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.
    Killick E; Morgan R; Launchbury F; Bancroft E; Page E; Castro E; Kote-Jarai Z; Aprikian A; Blanco I; Clowes V; Domchek S; Douglas F; Eccles D; Evans DG; Harris M; Kirk J; Lam J; Lindeman G; Mitchell G; Pachter N; Selkirk C; Tucker K; Zgajnar J; Eeles R; Pandha H
    Sci Rep; 2013; 3():2059. PubMed ID: 23792811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination.
    Marszałł MP; Sroka W; Adamowski M; Słupski P; Jarzemski P; Siódmiak J; Odrowąż-Sypniewska G
    Eur J Cancer Prev; 2015 Jan; 24(1):51-6. PubMed ID: 25003607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EN2 in Prostate Cancer.
    McGrath SE; Michael A; Morgan R; Pandha H
    Adv Clin Chem; 2015; 71():47-76. PubMed ID: 26411411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary EN-2 to predict prostate cancer: Systematic review and meta-analysis.
    Rosa MID; Dondossola ER; Alexandre MCM; Madeira K; Cardoso FA; Grande AJ
    Rev Assoc Med Bras (1992); 2017 Jul; 63(7):656-661. PubMed ID: 28977093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.
    Li Q; Shi Y; Sa R; Hao J; Hu J; Xiao M; Wang C; Yan L; Qiao B; Chen G
    BMC Cancer; 2020 Jun; 20(1):555. PubMed ID: 32539763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sensitive immunosensor for the selective detection of Engrailed 2 urinary prostate cancer biomarker.
    Mokni M; Tlili A; Attia G; Khaoulani S; Zerrouki C; Omezzine A; Othmane A; Bouslama A; Fourati N
    Biosens Bioelectron; 2022 Dec; 217():114678. PubMed ID: 36116221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer.
    Annels NE; Simpson GR; Denyer M; McGrath SE; Falgari G; Killick E; Eeles R; Stebbing J; Pchejetski D; Cutress R; Murray N; Michael A; Pandha H
    Clin Exp Immunol; 2014 Aug; 177(2):428-38. PubMed ID: 24654775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
    Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B
    Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
    McKiernan J; Donovan MJ; Margolis E; Partin A; Carter B; Brown G; Torkler P; Noerholm M; Skog J; Shore N; Andriole G; Thompson I; Carroll P
    Eur Urol; 2018 Dec; 74(6):731-738. PubMed ID: 30237023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.
    Fujita K; Hayashi T; Matsuzaki K; Nakata W; Masuda M; Kawashima A; Ujike T; Nagahara A; Tsuchiya M; Kobayashi Y; Nojima S; Uemura M; Morii E; Miyoshi E; Nonomura N
    Oncotarget; 2016 Aug; 7(35):56643-56649. PubMed ID: 27494861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
    Salami SS; Schmidt F; Laxman B; Regan MM; Rickman DS; Scherr D; Bueti G; Siddiqui J; Tomlins SA; Wei JT; Chinnaiyan AM; Rubin MA; Sanda MG
    Urol Oncol; 2013 Jul; 31(5):566-71. PubMed ID: 21600800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EN2: a novel prostate cancer biomarker.
    McGrath SE; Michael A; Morgan R; Pandha H
    Biomark Med; 2013 Dec; 7(6):893-901. PubMed ID: 24266821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.
    Ström P; Nordström T; Aly M; Egevad L; Grönberg H; Eklund M
    Eur Urol; 2018 Aug; 74(2):204-210. PubMed ID: 29331214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer.
    Kim E; Kang M; Ban C
    Sci Rep; 2022 Jul; 12(1):11523. PubMed ID: 35798816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
    Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
    Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker.
    Morgan R; Bryan RT; Javed S; Launchbury F; Zeegers MP; Cheng KK; James ND; Wallace DM; Hurst CD; Ward DG; Knowles MA; Pandha H
    Eur J Cancer; 2013 Jun; 49(9):2214-22. PubMed ID: 23434148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.